Pfizer Secures FDA Approval for Geodon Capsules for Bipolar Disorder in Adults
 From M2 Europharma - Nov 23, 2009
Pharmaceutical company Pfizer Inc announced on Friday the receipt of 
approval from the FDA for Geodon Capsules for maintenance treatment 
of bipolar I disorder in adults. The company said that the FDA 
approval is based on the efficacy and safety of Geodon in a 
six-month, double-blind, randomized, placebo-controlled trial in 
adult patients with bipolar I  disorder.

www.peoplewho.org